Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582010 · ClinicalTrials.gov registry record · Phase 2
Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation
A Phase 2 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 2
- Development phase
- 80
- Enrollment target
NCT00582010 is a Phase 2 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 80 participants.
The verdict
NCT00582010, a Phase 2 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 80 participants
- Enrollment target
Study Summary
This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide prevents liver injury associated with the restoration of blood flow. The premise of the current study is provided by previous studies which document a protective effect of inhaled nitric oxide in this clinical setting.
Interventions
- DRUG inhaled nitric oxide
- DRUG nitrogen gas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2008-04 |
| Est. Completion | 2012-10 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582010
The ClinicalTrials.gov registry entry for NCT00582010 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 80 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which inhaled nitric oxide is the first listed.
NCT00582010 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582010 about?
NCT00582010 is a clinical study titled "Study to Evaluate if Inhaled Nitric Oxide Improves Liver Function After Transplantation". This blinded, placebo-controlled study will administer inhaled nitric oxide to patients undergoing liver transplantation. The purpose of the study is to test if inhaled nitric oxide prevents liver injury associated with the restoration of blood flow. The premise of the current study is provided by p...
What is the current status of trial NCT00582010?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 80 participants. The study started on 2008-04. Estimated completion is 2012-10.
What interventions are being tested in trial NCT00582010?
The interventions under investigation include: inhaled nitric oxide (DRUG), nitrogen gas (DRUG).
Who is sponsoring clinical trial NCT00582010?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.